The human milk oligosaccharides market is anticipated to expand at a CAGR of 22.7% during the anticipated time frame. According to projections, the market would be worth US$ 1,539.21 Million by 2032, up from US$ 199.0 Million in 2022.

Human milk oligosaccharides (HMOs) are gaining popularity as people become more aware of their health benefits. Breast milk contains complex carbohydrates that are necessary for the immune system and digestive function of a baby. Increased research, technological advancements, and growing demand for functional additives are propelling the sector forward.

According to the World Health Organisation, the global population will increase by one billion people over the next ten years, reaching 9.5 billion by 2050. In actuality, supply greatly outstrips demand for baby feeding items. Meanwhile, infant formula sales are expanding in some Asian countries, including China and India, supporting the use of HMOs.  According to Future Market Insights, the global human milk oligosaccharides market will reach US$ 76 million by 2022, increasing at a 22.7% CAGR between 2022 and 2032.  This growth will be primarily driven by the increasing usage of HMO in infant nutrition products.

Get our Report Sample Now and Elevate Your Understanding

The European human milk oligosaccharides market is predicted to grow significantly in 2017 and beyond. Europe is predicted to account for more than 49% of the global market in terms of value by the end of 2027. In Europe, manufacturers are requesting for regulatory permits and product safety certificates to utilise HMO in the formulation of baby formulas. The North American HMO market is currently valued at approximately US$ 6 Mn, ranking second only to Europe in terms of market size.

FMI’s report, titled “Human Milk Oligosaccharides Market Global Industry Analysis and Opportunity Assessment, 2017 – 2027” also cites that demand for HMO is gaining traction due to a positive perception of its prebiotic properties that help maintain a healthy immune system in infants. In addition, manufacturers are focusing on increasing their production capacities in order to enhance production of HMOs such as 2’-FL (2-fucosyllactose) that can be potentially used as an ingredient in functional food and beverages. zuChem Inc., Glycosyn LLC, Elicityl SA, Jennewein Biotechnologie GmbH, Glycom A/S, Dextra Laboratories Limited, Carbosynth Limited, Inbiose NV, ProZyme, Inc. are the leading companies operating in the global human milk oligosaccharides market.

Key Excerpts of the Report Include:

  • Among product type, fucosyllactose HMO currently accounts for the largest value share of the market followed by sialyllactose HMO. However, the latter is expected to register a faster growth rate in terms of the market value over the forecast period.
  • By 2017-end, US$ 5.5 Mn worth sialyllactose HMO is expected to be consumed globally.
  • Increasing demand for functional food and beverage products is projected to further facilitate the growth of global human milk oligosaccharides market over the next couple of years.

Market Segmentation

By Product Type

  • Fucosyllactose
  • LNT & LNnT
  • Sialyllactose

By Region

  • North America
  • Europe
  • Asia Pacific

Lift the Veil on Our Methodological Excellence

Frequently Asked Questions

  • How big is the Human Milk Oligosaccharides Market?
  • At What Rate is Human Milk Oligosaccharides Market expected to rise?
  • What is the North America, Human Milk Oligosaccharides Market Outlook?
  • Which are the major countries driving demand for Human Milk Oligosaccharides Market?
  • At what rate will the China Human Milk Oligosaccharides Market grow?
  • At what rate will the Germany Human Milk Oligosaccharides Market grow?
  • At What Rate will, Human Milk Oligosaccharides Market Demand Grow in Europe?
  • Who are the top 5 players operating in the market?
  • At what rate will the Mexico Human Milk Oligosaccharides Market grow?
  • What is the outlook forecast for the Human Milk Oligosaccharides Market?

Human Milk Oligosaccharides Market by Category

By Product Type, Human Milk Oligosaccharides Market is Segmented as:

  • Fucosyllactose
  • LNT & LNnT
  • Sialyllactose

By Region Human Milk Oligosaccharides Market is Segmented as:

  • North America
  • Europe
  • Asia Pacific

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *